TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2023
Back to search
Official data from USPTO
M-GAGER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/07/2023
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
03/28/2022
Registration date
10/10/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
12/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Horgen, CH
Examiner
WHITE, TRAVIS
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CDR-Life AG
CDR-Life AG
Representatives
David M. Kelly KELLY IP, LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical preparations for medical usenamely for use in the treatment of cancer; Biological preparations for medical purposesnamely for use in the treatment of cancer; biotechnological products for medical usenamely medical preparations for the treatment of cancer; Pharmaceuticals for use in the treatment of cancer; Pharmaceutical preparations for use in the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatory preparations; Immunostimulants; Medicines for human purposes namelymedicinal preparations for the treatment of cancer; Medicines for veterinary purposes namelyveterinary pharmaceutical preparations for the treatment of cancer; Chemico-pharmaceutical preparations namelychemical preparations for pharmaceutical or medical purposesnamely for use in the treatment of cancer; Diagnostic agents for medical use; Pharmaceuticalsmedical and veterinary preparationsnamely pharmaceutical preparations for use in the treatment of cancer
Class 42
Scientific and medical research and development in the field of cancer; Biological and chemical research; Research relating to biotechnology; Pharmaceutical research and development; Research and development services in the field of immunology; Laboratory analysis in the field of molecular biology; Provision of information relating to medical and veterinary research and development in the field of cancer; Consultancy in the field of pharmaceutical research; Consultancy relating to research and development in the field of therapeutics; consultancy relating to biotechnology; Scientific laboratory services; Analytical laboratory serviceslaboratory analysis in the field of cancer; Services of a chemical or biological laboratorychemical and biological research and analysis; Research and development services for the pharmaceutical industry; Product development; Quality control for others; Research and development services in the field of antibodies; Scientific research services in the field of proteinsantibodiesmicroorganisms and cells; Scientific and technological servicesscientific analysis and research services in the field of cancer; Chemical analysis; Medical and scientific researchconducting clinical trials for others; Providing of information relating to medical and scientific research on pharmaceutical products
Publications
History of USPTO decisions and trademark events.
27 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/25/2023
PUBO
PUBLISHED FOR OPPOSITION
07/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/22/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/22/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/22/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/23/2023
GNRT
NON-FINAL ACTION E-MAILED
01/23/2023
CNRT
NON-FINAL ACTION WRITTEN
01/23/2023
DOCK
ASSIGNED TO EXAMINER
01/11/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/23/2022
ALIE
ASSIGNED TO LIE
05/22/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2022
NWAP
NEW APPLICATION ENTERED
03/31/2022
Continuous trademark protection
Get notified about every new filing that threatens M-GAGER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.